Le Lézard
Classified in: Health
Subjects: CCA, TDS, FVT

Encompass Health to present at Bank of America Merrill Lynch Health Care Conference


BIRMINGHAM, Ala., April 17, 2018 /PRNewswire/ -- Encompass Health Corporation (NYSE: EHC), formerly known as HealthSouth Corporation, today announced it will participate in the Bank of America Merrill Lynch Health Care Conference in Las Vegas, Nevada on May 15-17, 2018.

 (PRNewsfoto/Encompass Health Corporation)

Encompass Health Executive Vice President and Chief Financial Officer Doug Coltharp will participate in a fireside chat at 11:40 a.m. ET/8:40 a.m. PT on Wednesday, May 16, 2018. The presentation will be webcast live and will be available at http://investor.encompasshealth.com by clicking on an available link.  

About Encompass Health
As a national leader in post-acute care, Encompass Health (NYSE: EHC) offers both facility-based and home-based patient care through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies. With a national footprint that spans 127 hospitals and 237 home health & hospice locations in 36 states and Puerto Rico, the Company is committed to delivering high-quality, cost-effective care across the post-acute continuum. Driven by a set of shared values, Encompass Health is the result of the union between HealthSouth Corporation and Encompass Home Health & Hospice, and is ranked as one of Fortune's 100 Best Companies to Work For, as well as Modern Healthcare's Best Places to Work. For more information, visit encompasshealth.com, or follow us on Twitter and Facebook.

Media Contact  
Casey Lassiter, 205 447-6410                                                                   
[email protected]      

Investor Relations Contact
Crissy Carlisle, 205 970-5860
[email protected]

SOURCE Encompass Health Corporation


These press releases may also interest you

at 06:10
Confo Therapeutics, a leader in the discovery of novel medicines targeting G-protein coupled receptors (GPCRs), announced today that it has been awarded a EUR 1.6 million grant from Flanders Innovation & Entrepreneurship (VLAIO). The 2-year grant...

at 06:08
Aesthetic Management Partners LLC, a manufacturer of skin-based solutions and a provider of energy-based devices announces its collaboration with Croma (Croma-Pharma® GmbH), a global player in the minimally invasive aesthetics market and a leading...

at 06:05
The 2023 U.S. soybean field trials conducted by Texas Crop Science (TCS) demonstrated an average yield increase of 21% in soybean lines incorporating the TCS yield trait. This breakthrough in performance would generate approximately $121 per acre in...

at 06:05
3EO Health, a "Point of Life" diagnostics company focused on the development of high-performing low-cost molecular diagnostics, is excited to announce the next step in their quest to make molecular testing affordable. Today, the company has published...

at 06:05
Zura Bio Limited ("Zura Bio") a clinical-stage immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases, today reported full year 2023 financial results and recent business highlights. The Company has also...

at 06:00
Zymeworks Inc. , a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to-treat diseases, today announced the appointment of Dr. Neil Gallagher to...



News published on and distributed by: